Mylan CEO Bresch: 'No one's more frustrated than me' about EpiPen price furor. Mylan CEO Heather Bresch struggled Thursday to justify the repeated big price hikes of the company's lifesaving EpiPen devices as criticism continued that Mylan is gouging consumers with a retail cost of more than $600.